Posts
April 26 2017
Apricus Biosciences, Inc. announced the closing of their Underwritten offering in the amount of $7,042,000. EG&S acted as counsel to the Underwriter.
April 24 2017
Sunshine Heart, Inc. announced the closing of their Underwritten offering in the amount of $8,372,000. EG&S acted as counsel to the Underwriter.
April 21 2017
Social Reality Inc. announced the closing of their PIPE offering in the amount of $5,000,000. EG&S acted as counsel to the lead Investor.
April 19 2017
DelMar Pharmaceuticals, Inc. announced the closing of their Registered Direct offering in the amount of $9,000,000. EG&S acted as counsel to the Placement Agent.
April 18 2017
SkyPeople Fruit Juice, Inc. announced the closing of their Registered Direct offering in the amount of $2,672,500. EG&S acted as counsel to the Placement Agent.
April 17 2017
Cytori Therapeutics announced the closing of a confidentially marketed public offering of common stock in the amount of $8.8 million. EG&S acted as counsel to the underwriter, Maxim Group LLC.
April 12 2017
Forum Merger Corporation, a company formed for the purpose of entering into a merger, share exchange, asset acquisition or other similar business combination with one or more businesses or entities, announced the closing of its initial public offering in the amount of $150,000,000. EG&S acted as counsel to Forum Merger.
April 12 2017
Blink Health announced that it has raised a $90 million Series B equity funding led by 8VC, bringing its total venture capital funding to $165 million. Blink Health is a technology platform that enables consumers to access the medications at affordable prices through over 57,000 pharmacies nationwide. EGS acted as counsel to Blink Health.